Otosclerosis: Difference between revisions

Jump to navigation Jump to search
Line 133: Line 133:
*Perilymph fistula: Progressive hearing loss, Tinnitus, or vertigo.
*Perilymph fistula: Progressive hearing loss, Tinnitus, or vertigo.
*Taste disturbance
*Taste disturbance
*Facial nerve injury  
*Facial nerve injury
*Sensorineural hearing loss
*Sensorineural hearing loss
*Post stapedectomy granulomas
*Post stapedectomy granulomas
*Vertigo
*Vertigo
===Prognosis===
===Prognosis===
Most of the patients find improvement in their hearing ability after the surgery. Only a few don't have any change post-surgery and rarely hearing loss worsens. There have been cases where the prosthesis was found displaced from its original position, causing conductive hearing loss again in some patients. The second surgery was observed to be less successful than the first.
 
* Most of the patients find improvement in their hearing ability after the surgery.  
* Only a few don't have any change post-surgery and rarely hearing loss worsens.  
* There have been cases where the prosthesis was found displaced from its original position, causing conductive hearing loss again in some patients.  
* The second surgery was observed to be less successful than the first.


==Diagnosis==
==Diagnosis==

Revision as of 16:46, 25 March 2021

WikiDoc Resources for Otosclerosis

Articles

Most recent articles on Otosclerosis

Most cited articles on Otosclerosis

Review articles on Otosclerosis

Articles on Otosclerosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Otosclerosis

Images of Otosclerosis

Photos of Otosclerosis

Podcasts & MP3s on Otosclerosis

Videos on Otosclerosis

Evidence Based Medicine

Cochrane Collaboration on Otosclerosis

Bandolier on Otosclerosis

TRIP on Otosclerosis

Clinical Trials

Ongoing Trials on Otosclerosis at Clinical Trials.gov

Trial results on Otosclerosis

Clinical Trials on Otosclerosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Otosclerosis

NICE Guidance on Otosclerosis

NHS PRODIGY Guidance

FDA on Otosclerosis

CDC on Otosclerosis

Books

Books on Otosclerosis

News

Otosclerosis in the news

Be alerted to news on Otosclerosis

News trends on Otosclerosis

Commentary

Blogs on Otosclerosis

Definitions

Definitions of Otosclerosis

Patient Resources / Community

Patient resources on Otosclerosis

Discussion groups on Otosclerosis

Patient Handouts on Otosclerosis

Directions to Hospitals Treating Otosclerosis

Risk calculators and risk factors for Otosclerosis

Healthcare Provider Resources

Symptoms of Otosclerosis

Causes & Risk Factors for Otosclerosis

Diagnostic studies for Otosclerosis

Treatment of Otosclerosis

Continuing Medical Education (CME)

CME Programs on Otosclerosis

International

Otosclerosis en Espanol

Otosclerosis en Francais

Business

Otosclerosis in the Marketplace

Patents on Otosclerosis

Experimental / Informatics

List of terms related to Otosclerosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: CSN, M.D.

Synonyms and keywords:

Overview

Otosclerosis is a word derived from the Greek word "sklērós" meaning hardening and oto meaning ear. Otosclerosis is an osseous dyscrasia of the otic capsule, which should be an endochondral dense bony part in the labyrinth, replaced by irregularly laid spongy bone leading to the fixation of stapes. It is one of the most common causes of conductive deafness with normal tympanic membranes. Thereby affecting sound transmission to the inner ear at the level of the oval window Though majority of cases are observed at the oval window, otosclerosis can also affect the round window, cochlear apex, posterior to the oval window, posterior and anterior wall of the internal auditory canal (IAC), cochlear aqueduct, semicircular canals, and within the stapes footplate. It can be asymptomatic or in advanced cases extend into the bony labyrinth and affect cochlea which causes mixed conductive and sensorineural hearing loss depending on the position of foci. Otosclerosis is common in Caucasians and predominantly women. Hormonal fluctuations in women like during pregnancy and menopause may aggravate the disease. Many genetic factors contribute to the development of otosclerosis. And it is an autosomal dominant inheritance with incomplete penetrance. Measles was found to be one of the reasons for otosclerosis. Other factors include inflammatory cytokine and cytotoxic mediators secondary to inflammation. (CT) scanning of the temporal bone can often demonstrate foci of demineralization in the otic capsule in cases of cochlear otosclerosis. The treatment for hearing loss is essentially stapes surgery with successful improvement of 90%-95% in the first 5 years; decreases to 63% after 30years and rarely need revision surgery. Additionally, hearing aid and cochlear implants could be used along with surgery.

Historical Perspective

  • 1704:Antonio Maria Valsalva identified fixation of stapes as a cause of hearing loss
  • 1841:Toyn bee stated, "osseous ankylosis of the stapes to the fenestra ovalis as one of the causes of deafness".
  • 1876:Johannes Kessel described stapes surgery as the treatment.
  • 1930-1950: Used Julius Lempert’s single-stage fenestration of stapes as treatment.
  • 1956:John Shea modernized stapedectomy.

Classification

Based on Symons/fanning grading system otosclerosis can be classified into
  • Grade 1: Fenestral Otosclerosis
  • Grade 2: Cochlear Otosclerosis
    • Grade 2A:Basal cochlear turn Otosclerosis
    • Grade 2B:Middle/Apical turn Otosclerosis
    • Grade 2C:Both Basal and Middle/apical Otosclerosis
  • Grade 3:Diffuse confluent cochlear involvement (with or without fenestral involvement)

Pathophysiology

Embryology

Table explains the embryological process for the development of bony labyrinth

Gestational week Developmental process
4th week
  • Development of otic canal from mesenchyme of otic vesicle by forming an otic capsule around it
8th week
  • Initiation of the cartilaginous framework
16th week
  • Endochondrial replacement of the cartilaginous framework.
  • In certain cases, completion of the third stage of bone formation doesn't occur leading to cartilages between bony structures.
  • During labyrinth bone formation, the anterior to the oval window is usually the last area to develop. This area is the most common site for otosclerosis.

Pathogenesis

  • Accumulation of bone deposits because of increased bone remodeling which is bone resorption followed by bone deposition in the otic capsule result in otosclerosis.
  • Audiological findings are directly proportionate to the extent of bone remodeling.
  • Bone remodeling happens in 3 phases:
Phase Mechanism of action
Otospongiosis Increase in both osteoclast activity and microvascularity
Transitional phase begins with deposits of spongy bone by osteoblasts in areas of previous bone reabsorption
Otosclerotic phase characterized by spongy bone deposits developing into dense bone that narrows the microcirculation previously developed in the otospongiosis phase
  • The lesions occur mostly in the anterior to the oval window by calcifying of annular ligament or by involving stapes footplate (80%).
  • While 30% of cases have the lesion at the round window,21% have it at peri cochlear region, and 19% at the anterior segment of the internal auditory canal.

Associated Conditions

Conditions associated with otosclerosis include:

  • Pregnancy
There is no strong evidence why pregnancy worsens hearing loss in some patients with otosclerosis.However 33% women with otosclerosis are found to deteriote in hering after one pregnancy.
  • Measles
RNA of measles virus was detected at the footplate of stapes in otosclerotic patients , suggesting its role in casuing it, while incidence has reduced significantly in vaccinated populations.
  • Trauma and Major surgeries also cause otosclerosis.
  • Autoimmune
Though research on this is in the initial stages, inflammatory cytokine like TNF-alpha and cytotoxic mediators were found at the otosclerotic bone suggesting its role in the pathology.[1]

Causes

Common causes of otosclerosis include:

Embryological Cause
  • During the maturation of the otic capsule of the labyrinth, certain places skip the complete conversion to endochondral, leading to irregularly laid spongy bone. This most commonly is seen at fissula ante fenestram.[2]
Genetic Cause
  • Studies have been conducted and found Type 1 collagen gene(COL1A1), a component essential for bone metabolism plays a role in otosclerosis.
  • TGF-beta 1(BMP 2 and BMP 4 gene and Angiotensin II (AGT M235T and ACE I/D genes) are also found associated with otosclerosis.
  • Other genetic causes for otosclerosis include sex hormones, autoimmune reaction, human leucocyte antigen, inflammatory and regulatory cytokines, parathyroid hormone, and expression of parathyroid hormone-related peptides receptors, and oxidative stress

Differentiating ((Page name)) from other Diseases

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

OR

[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].

Epidemiology and Demographics

  • Though a variable pattern of inheritance is observed, 60% of patients report a family with a history of otosclerosis. Thus researchers conclude this condition as an autosomal dominant with incomplete penetrance.
  • Greater preponderance in women compared to men in a ratio of 2:1.
  • Even though the disease begins in the second and third decade of life, it doesn't result in hearing loss until the fourth decade.
  • Clinical prevalence of otosclerosis is found to be higher in Caucasians by 0.04%-1% while the histological incidence of otosclerosis increases to 10% in the same..The incidence of histological otosclerosis is 1% and 5% in African and Asian population respectively.

Risk Factors

Common risk factors in the development of otosclerosis include

  • Genetic factor
Otosclerosis is an autosomal dominant disease with incomplete penetrance. When 60% of patients were found with family history, 40-50% of patients have it with variable patterns of inheritance. But hearing loss in otosclerosis is found only with family history of the same.[3]
  • Hormonal conditions
Puberty, pregnancy, and menopause increase the occurrence of hearing loss in pre-existing otosclerosis.
  • Measles
Persistent measles virus infection of stapes footplate results in activated osteoclast and inflammatory pathways by TNF-alpha mRNA. The protective function of osteoprotegerin at the otic capsule is inhibited by TNF-alpha and its action on RANK production[4]

Screening

Even though otosclerosis appears to be genetic deafness, early prevention can help in combating the disorder and its prevention.

  1. Systematic Impedance-audiometry screening: The purpose of this screening is to detect a possible diphasic impedance change (on-off effect) by eliciting stapedius reflex. It is done in school going-children and helps in the early detection of stapedial fixation.
  2. Systematic Bone-conducted audiometry screening: It is done in young children with a family history of otosclerosis.

Natural History, Complications, and Prognosis

Complications

Post-op complications of otosclerosis include:

  • Perilymph fistula: Progressive hearing loss, Tinnitus, or vertigo.
  • Taste disturbance
  • Facial nerve injury
  • Sensorineural hearing loss
  • Post stapedectomy granulomas
  • Vertigo

Prognosis

  • Most of the patients find improvement in their hearing ability after the surgery.
  • Only a few don't have any change post-surgery and rarely hearing loss worsens.
  • There have been cases where the prosthesis was found displaced from its original position, causing conductive hearing loss again in some patients.
  • The second surgery was observed to be less successful than the first.

Diagnosis

Diagnostic Study of Choice

The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].

OR

The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].

OR

The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].

OR

There are no established criteria for the diagnosis of [disease name].

History and Symptoms

The majority of patients with [disease name] are asymptomatic.

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

Physical Examination

Patients with [disease name] usually appear [general appearance]. Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].

OR

Common physical examination findings of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

The presence of [finding(s)] on physical examination is diagnostic of [disease name].

OR

The presence of [finding(s)] on physical examination is highly suggestive of [disease name].

Laboratory Findings

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

OR

[Test] is usually normal among patients with [disease name].

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

OR

There are no diagnostic laboratory findings associated with [disease name].

Electrocardiogram

There are no ECG findings associated with [disease name].

OR

An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

X-ray

There are no x-ray findings associated with [disease name].

OR

An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with [disease name].

OR

Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Other Imaging Findings

There are no other imaging findings associated with [disease name].

OR

[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

There are no other diagnostic studies associated with [disease name].

OR

[Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

There is no treatment for [disease name]; the mainstay of therapy is supportive care.

OR

Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].

OR

The majority of cases of [disease name] are self-limited and require only supportive care.

OR

[Disease name] is a medical emergency and requires prompt treatment.

OR

The mainstay of treatment for [disease name] is [therapy].

OR   The optimal therapy for [malignancy name] depends on the stage at diagnosis.

OR

[Therapy] is recommended among all patients who develop [disease name].

OR

Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].

OR

Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].

OR

Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].

OR

Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].

Surgery

Surgical intervention is not recommended for the management of [disease name].

OR

Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]

OR

The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The feasibility of surgery depends on the stage of [malignancy] at diagnosis.

OR

Surgery is the mainstay of treatment for [disease or malignancy].

Primary Prevention

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Secondary Prevention

There are no established measures for the secondary prevention of [disease name].

OR

Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].

References

  1. Rudic M, Keogh I, Wagner R, Wilkinson E, Kiros N, Ferrary E; et al. (2015). "The pathophysiology of otosclerosis: Review of current research". Hear Res. 330 (Pt A): 51–6. doi:10.1016/j.heares.2015.07.014. PMID 26276418.
  2. Rudic M, Keogh I, Wagner R, Wilkinson E, Kiros N, Ferrary E; et al. (2015). "The pathophysiology of otosclerosis: Review of current research". Hear Res. 330 (Pt A): 51–6. doi:10.1016/j.heares.2015.07.014. PMID 26276418.
  3. Rudic M, Keogh I, Wagner R, Wilkinson E, Kiros N, Ferrary E; et al. (2015). "The pathophysiology of otosclerosis: Review of current research". Hear Res. 330 (Pt A): 51–6. doi:10.1016/j.heares.2015.07.014. PMID 26276418.
  4. Karosi T, Jókay I, Kónya J, Szabó LZ, Pytel J, Jóri J; et al. (2006). "Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity". Laryngoscope. 116 (8): 1427–33. doi:10.1097/01.mlg.0000225928.35838.e5. PMID 16885748.


Template:WikiDoc Sources